BIRC5 and melanoma: With respect to protein delivery, Aspe et al. [242] engineered EVs from melanoma cells to overexpress survivin-T34A, which is a dominant-negative mutant variant of the inhibitor of apoptosis protein survivin that blocks the protein’s function.